2014
DOI: 10.3109/01658107.2013.879903
|View full text |Cite
|
Sign up to set email alerts
|

Neuromyelitis Optica Spectrum Disorder in a Chinese Woman with Ocular Myasthenia Gravis: First Reported Case in the Chinese Population

Abstract: Coexisting myasthenia gravis and neuromyelitis optica spectrum disorder was reported as a rare association, with only 26 reported cases in the literature. The authors report the case of a middle-aged Chinese woman with bilateral recurrent optic neuritis and seropositive ocular myasthenia gravis who was subsequently diagnosed with neuromyelitis optica spectrum. She was tested seropositive for the neuromyelitis optica immunoglobulin G (NMO-IgG) and had elevated antinuclear antibody titres, but workup for other a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 21 publications
0
2
0
Order By: Relevance
“…However, the coexistence of these two pathologies is evident in some cases where patients never underwent thymectomy. [4][5][6][7][8]10,13,14 or presented NMO before having such surgical procedure done, 4 suggesting that the thymus is not the only responsible factor.…”
Section: Literature Review and Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…However, the coexistence of these two pathologies is evident in some cases where patients never underwent thymectomy. [4][5][6][7][8]10,13,14 or presented NMO before having such surgical procedure done, 4 suggesting that the thymus is not the only responsible factor.…”
Section: Literature Review and Discussionmentioning
confidence: 99%
“…These anti-AQP4 Abs, also called NMO IgG Abs, are used as a specific test for Neuromyelitis Optica Spectrum Disorders (NMOSD), with a specificity of 99-100% and a sensitivity of 58-91%, though detection rates vary among different laboratory tests, with patients within the NMOSD group being seronegative. 5,6 The prevalence of NMOSD ranges around 3.9 to 10 with an incidence of 0.07 to 0.73 per 100,000 individuals respectively; the difference between women and men is 8-9:1 (1). Higher associations with autoimmune diseases have been reported in seropositive NMOSD patients in up to 25-50% of cases (4), including Systemic Lupus Erythematosus (SLE), Sjögren's syndrome (SS), autoimmune thyroid diseases, and MG (5).…”
Section: Introductionmentioning
confidence: 99%